“The addition of RYTSTAT further strengthens our nephrology portfolio in India," said Kirti Ganorkar, CEO - India Business, Sun Pharma.
from Healthcare/Biotech-Industry-Economic Times https://ift.tt/xn07hJU
via IFTTT
Home »
Healthcare/Biotech-Industry-Economic Times
» Sun Pharma to market Zydus' novel anti-CKD drug desidustat in India
0 comments:
Post a Comment